ZVSA
ZyVersa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.10
−0.20%Leverage
- Debt / equity
- -84.96x
- Net debt / equity
- -63.53x
- Debt / assets
- 1.62x
- Debt / EBITDA
- -48.59x
- Net debt / EBITDA
- -36.34x
Liquidity & coverage
- Current ratio
- 0.05x
- Quick ratio
- 0.05x
- Cash ratio
- 0.02x
- Interest coverage
- —
- EBITDA / interest
- -46.93x
- Working capital
- -$14.1B
Cash & dividend
- FCF / debt
- -2.18x
- Cash flow / debt
- -2.18x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026